Tune Therapeutics Secures $175M to Advance Clinical Trials in Seattle

In one of the biggest fundraising rounds for a startup in the Seattle area in recent years, Tune Therapeutics, a biotech business with headquarters in Durham, North Carolina, and Seattle, raised $175 million. Tune involves controlling gene expression without changing…